Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast CancerSilvia Martini, Valentina Zuco, Monica Tortoreto, et al.
Journal of Proteome Research|December 15, 2010
Proteomic analysis of cellular response to novel proapoptotic agents related to atypical retinoids in human IGROV-1 ovarian carcinoma cellsAlberto Milli, Paola Perego, Giovanni L Beretta, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2019
miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibitionRihan El Bezawy, Stella Tinelli, Monica Tortoreto, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2008
Intracellular accumulation and DNA damage persistence as determinants of human squamous cell carcinoma hypersensitivity to the novel camptothecin ST1968Claudio Pisano, Valentina Zuco, Michelandrea De Cesare, et al.
European Journal of Medicinal Chemistry|September 20, 2016
[1,2]Oxazolo[5,4-e]isoindoles as promising tubulin polymerization inhibitorsVirginia Spanò, Marzia Pennati, Barbara Parrino, et al.
European Journal of Medicinal Chemistry|February 19, 2016
Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activityRaffaella Cincinelli, Vincent Zwick, Loana Musso, et al.
Bioorganic & Medicinal Chemistry|May 22, 2007
Synthesis and structure-activity relationships of new antiproliferative and proapoptotic retinoid-related biphenyl-4-yl-acrylic acidsRaffaella Cincinelli, Sabrina Dallavalle, Raffaella Nannei, et al.
Neoplasia (New York, N.Y.)|July 20, 2005
Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage responseValentina Zuco, Chiara Zanchi, Cinzia Lanzi, et al.
European Journal of Medicinal Chemistry|December 17, 2008
Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitorsSabrina Dallavalle, Raffaella Cincinelli, Raffaella Nannei, et al.
Cancers|June 10, 2020
SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage RepairRihan El Bezawy, Martina Tripari, Stefano Percio, et al.
Pageof 7